PALLEIKO BENJAMIN L (CFO and Secretary) sold 2.0% of their position (9.55K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $193.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/20/2026ACC: 0001366244-26-000006
Officer· CFO and Secretary
Since Sep 2018
-9.55K
Net shares
Net seller
$193.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
20.31K acquired · 29.86K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+20.31K
Price / share
—
Trade value
—
% of position
4.5%
4/16/2026
451.81K→472.13K
Common Stock
Direct
Shares
−9.55K
Price / share
$20.22
Trade value
$193.07K
% of position
2.0%
4/17/2026
472.13K→462.58K
Total
Net shares
+10.76K
Net value
-$193.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/16/2026 | M · Option Exercise | +20.31K | — | — | 4.5% | 451.81K | 472.13K |
| Common Stock Direct | 4/17/2026 | S · Sale | −9.55K | $20.22 | $193.07K | 2.0% | 472.13K | 462.58K |
| Total | +10.76K | -$193.07K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
20.31K shares
Shares
−20.31K
Strike price
Held after
304.69K
Exercisable
—
4/16/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock20.31K shares | 4/16/2026 | M · Option Exercise | −20.31K | — | 304.69K |